Travere Therapeutics TVTX
NASDAQ TVTX
$58.88 -1.11 (-1.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) FCF Margin (2014 - 2026)

Updated

Travere Therapeutics (TVTX) posted FCF Margin of 34.24% for Q2 2026, up 29.89 percentage points from 4.35% a year earlier and up 65.98 percentage points from the prior quarter.

Analysis

Travere Therapeutics (TVTX) FCF Margin (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, FCF Margin at Travere Therapeutics was 15.65%, up 50.23 percentage points year-over-year; for FY2025, it was 7.70%, up 109.54 percentage points from FY2024.

  • Annual FCF Margin has increased for four consecutive years, with a five-year change of +32.66 percentage points (FY2020 to FY2025).
  • In prior years, Travere Therapeutics' FCF Margin was -101.84% in FY2024 (+122.63 pp), -224.48% in FY2023 (+14.00 pp), -238.48% in FY2022 (+439.35 pp) and -677.83% in FY2021 (-652.86 pp).
  • Quarterly FCF Margin has run from a low of -737.31% in Q4 2021 to a high of 46.79% in Q4 2025 over five years.
  • On a year-over-year basis, FCF Margin has increased in each of the last 12 quarters, with an average year-over-year change of +95.45 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2022, with a gain of 475.77 percentage points; the weakest was Q4 2021, with a drop of 702.57 percentage points.
  • According to Business Quant data, FCF Margin for the three prior quarters was -31.73% (Q1 2026), 46.79% (Q4 2025) and 8.60% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.82%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 18.33%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 26.96%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 43.05%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 34.72%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.70%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 44.00%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 30.39%
10 Travere Therapeutics 5.55 Bn 5.14 Bn 167.41 Mn 34.24%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.24%
Mar 31, 2026 -31.73%
Dec 31, 2025 46.79%
Sep 30, 2025 8.60%
Jun 30, 2025 4.35%
Mar 31, 2025 -51.62%
Dec 31, 2024 -47.76%
Sep 30, 2024 -67.58%
Jun 30, 2024 -74.52%
Mar 31, 2024 -287.63%
Dec 31, 2023 -142.92%
Sep 30, 2023 -200.67%
Jun 30, 2023 -273.05%
Mar 31, 2023 -321.42%
Dec 31, 2022 -261.54%
Sep 30, 2022 -327.80%
Jun 30, 2022 -128.60%
Mar 31, 2022 -236.85%
Dec 31, 2021 -737.31%
Sep 30, 2021 46.49%
API Access

Travere Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY